Log In
BCIQ
Print this Print this
 

cgtx_F/cgtx_G

  Manage Alerts
Collapse Summary General Information
Company conoGenetix biosciences GmbH
DescriptionKv1.3 potassium ion channel antagonist
Molecular Target Potassium channel Kv1.3 (KCNA3)
Mechanism of ActionK channel blocker
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today